---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-106087"
form_type: "8-K"
ticker: "TLSI"
cik: "0001826667"
company_name: "TriSalus Life Sciences, Inc."
filed_at: "2023-10-03T23:59:59+00:00"
generated_at: "2026-06-10T05:36:59.348442+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# TriSalus enters $30M standby equity purchase agreement with Yorkville; authorizes up to $4M warrant repurchase

## Summary
- Entered Standby Equity Purchase Agreement to sell up to $30M common stock to Yorkville at 96-97% of VWAP.
- Paid $25,000 structuring fee and $300,000 commitment fee; registration statement required before sales.
- Board authorized repurchase of publicly-held warrants for up to $4 million.
- Advances capped by 4.99% ownership limit and 19.99% exchange cap on outstanding stock.

## SEC filing metadata
- accession: 0001104659-23-106087
- form_type: 8-K
- ticker: TLSI
- cik: 0001826667
- company_name: TriSalus Life Sciences, Inc.
- filed_at: 2023-10-03T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 3.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1826667/000110465923106087/0001104659-23-106087-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1826667/000110465923106087/tm2327123d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-106087
- JSON: https://secwatch.observer/filing/0001104659-23-106087.json
- Plain text: https://secwatch.observer/filing/0001104659-23-106087.txt

## Key facts
- Material Agreements
  TriSalus Life Sciences, Inc. entered into Standby Equity Purchase Agreement with YA II PN, Ltd. (Yorkville) valued at up to $30,000,000 (effective 2023-10-02).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: YA II PN, Ltd. (Yorkville)
  - Value: up to $30,000,000
  - Effective: 2023-10-02
  source text: On October 2, 2023, TriSalus Life Sciences, Inc. (the “Company”) entered into a Standby Equity Purchase Agreement (the “Purchase Agreement”) with YA II PN, Ltd. (“Yorkville”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1826667/000110465923106087/0001104659-23-106087-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.